Banquiao, Via S.
HRN: 03-40-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2023
CEFUROXIME 500MG (TAB)
08/04/2023
08/11/2023
PO
500 Mg
BID
UTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes